PACE4-Based Molecular Targeting of Prostate Cancer Using an Engineered 64Cu-Radiolabeled Peptide Inhibitor
Author:
Publisher
Elsevier BV
Subject
Cancer Research
Reference58 articles.
1. 18F-FDG-PET/CT;Chierichetti;Q J Nucl Med Mol Imaging,2012
2. Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose;Effert;J Urol,1996
3. Recommendations on the use of 18F-FDG PET in oncology;Fletcher;J Nucl Med,2008
4. Non-[18F]FDG PET in clinical oncology;Groves;Lancet Oncol,2007
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy of PACE4 pharmacotherapy in JHU-LNCaP-SM preclinical model of androgen independent prostate cancer;Scientific Reports;2022-10-19
2. PCSK6 Is a Key Protease in the Control of Smooth Muscle Cell Function in Vascular Remodeling;Circulation Research;2020-02-28
3. Enhanced anti-tumor activity of the Multi-Leu peptide PACE4 inhibitor transformed into an albumin-bound tumor-targeting prodrug;Scientific Reports;2019-02-14
4. Development of a novel drug targeting delivery system for cervical cancer therapy;Nanotechnology;2018-12-19
5. Harnessing the Coordination Chemistry of 1,4,7-Triazacyclononane for Biomimicry and Radiopharmaceutical Applications;ChemPlusChem;2018-05-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3